Coupling of a signal response domain in IκBα to multiple pathways for NF-κB activation

Molecular and Cellular Biology

Volumn 15, Issue 5, 1995, Pages 2809-2818

  Brockman, Jeffrey A ^a   Scherer, David C ^a   McKinsey, Timothy A ^a   Hall, Sarah M ^a   Qi, Xiaoxia ^a   Lee, Wha Young ^a   Ballard, Dean W ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR;

ARTICLE; DELETION MUTANT; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOSTIMULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; SIGNAL TRANSDUCTION; STIMULUS RESPONSE; T LYMPHOCYTE ACTIVATION; TRANSACTIVATION;

EUKARYOTA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 0028929371     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/mcb.15.5.2809     Document Type: Article

References (89)

1. Alessi, D. R., Y. Saito, D. G. Campbell, P. Cohen. G. Sithanandam. U. Rapp, A. Ashworth, C. J. Marshall, and S. Cowley. 1994. Identification of the sites in MAP kinase kinase-1 phosphorylated by p74raf-1. EMBO J. 13:1610-1619.
2. Andersson, S., D. L. Davis, H. Dahlback, H. Jörnvall. and D. W. Russell. 1989. Cloning, structure, and expression of the mitochondrial cytochrome P-450 sterol 26-hydroxylase, a bile acid biosynthetic enzyme. J. Biol. Chem. 264:8222-8229.
3. Baeuerle, P., and D. Baltimore. 1988. Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-κB transcription factor. Cell 53:211-217.
4. Baeuerle, P., and D. Baltimore. 1988. IκB: a specific inhibitor of the NF-κB transcription factor. Science 242:540-546.
5. Baeuerle, P., and D. Baltimore. 1989. A 65-kD subunit of active NF-κB is required for inhibition of NF-κB by κB. Genes Dev. 3:1689-1698.
6. Ballard, D. W., E. Böhnlein, J. W. Lowenthal, Y. Wano, B. R. Franza, and W. C. Greene. 1988. HTLV-I Tax induces cellular proteins that activate the κB element in the IL-2 receptor α gene. Science 241:1652-1655.
7. Ballard, D. W., E. P. Dixon, N. J. Peffer, H. Bogerd, S. Doerre, B. Stein, and W. C. Greene. 1992. The 65-kDa subunit of human NF-κB functions as a potent transcriptional activator and a target for v-Rel-mediated repression. Proc. Natl. Acad. Sci. USA 89:1875-1879.
8. Ballard, D. W., W. H. Walker, S. Doerre, P. Sista, J. A. Molitor, E. P. Dixon, N. J. Peffer, M. Hannink, and W. C. Greene. 1990. The v-rel oncogene encodes a κB enhancer binding protein that inhibits NF-κB function. Cell 63:803-814.
9. Beg, A. A., and A. S. Baldwin, Jr. 1993. The IκB proteins: multifunctional regulators of Rel/NF-κB transcription factors. Genes Dev. 7:2064-2070.
10. Beg, A. A., T. S. Finco, P. V. Nantermet, and A. S. Baldwin, Jr. 1993. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of IκBα. a mechanism for NF-κ activation. Mol. Cell. Biol. 13:3301-3310.
11. Beg, A. A., S. M. Ruben, R. I. Scheinman, S. Haskill, C. A. Rosen, and A. S. Baldwin, Jr. 1992. IκB interacts with the nuclear localization sequences of the subunits of NF-κB: a mechanism for cytoplasm retention. Genes Dev. 6:1899-1913.
12. Béraud, C., S.-C. Sun, P. Ganchi, D. W. Ballard, and W. C. Greene. 1994 Human T-cell leukemia virus type 1 tax associates with and is negatively regulated by the NF-κB2 P100 gene product: implications for viral latency. Mol. Cell. Biol. 14:1374-1382.
13. Blanar, M., and W. J. Rutter. 1992. Interaction cloning: identification of a helix-loop-helix zipper protein that interacts with c-fos. Science 256:1014-1018.
14. Böhnlein, E., J. W. Lowenthal, M. Siekevitz, D. W. Ballard, B. R. Franza, and W. C. Greene. 1988. The same inducible nuclear protein(s) regulates mitogen activation of both the interleukin-2 receptor-alpha gene and type I HIV. Cell 53:827-836.
15. Böhnlein, E., M. Siekevitz, D. W. Ballard, J. W. Lowenthal, L. Rimsky, H. Bogerd, J. Hoffman, Y. Wano, B. R. Franza, and W. C. Greene. 1989. Stimulation of human immunodeficiency virus type I enhancer by the human T-cell leukemia virus type I tax gene product involves the activation of inducible cellular proteins. J. Virol. 63:1578-1586.
16. Bours, V., J. Villalobos, P. R. Burd, K. Kelly, and U. Siebenlist. 1990. Cloning of a mitogen-inducible gene encoding a κN DNA-binding protein with homology to the rel oncogene and to cell-cycle motifs. Nature (London) 348:76-80.
17. Boyle, W., P. van der Geer, and T. Hunter. 1991. Phosphopeptide mapping and phosphoamino acid analysis by two-dimensional separation on thin-layer cellulose plates. Methods Enzymol. 201:110-149.
18. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
19. Brown, K., S. Park, T. Kanno, G. Franzoso, and U. Siebenlist. 1993. Mutual regulation of the transcriptional activator NF-κB and its inhibitor, IκBα. Proc. Natl. Acad. Sci. USA 90:2532-2536.
20. Cordle, S. R., R. Donald, M. A. Read, and J. Hawiger. 1993. Lipopolysaccharide induces phosphorylation of MAD3 and activation of c-Rel and related NF-κB proteins in human monocytic THP-1. J. Biol. Chem. 268: 11803-11810.
21. Cross, S. L., M. B., Feinberg, J. B. Wolf, N. J. Holbrook, F. Wong-Staal. and W. J. Leonard. 1987. Regulation of the human interleukin-2 receptor α chain promoter: activation of a nonfunctional promoter by the transactivator gene of HTLV-I. Cell 49:47-56.
22. Davis, N., S. Ghosh, D. L. Simmons, P. Tempst, H. C. Liou, D. Baltimore, and H. R. Bose, Jr. 1991. Rel-associated pp40: an inhibitor of the rel family of transcription factors. Science 253:1268-1271.
23. deMartin, R., B. Vanhove, Q. Cheng, E. Hofer, V. Csizmadia, H. Winkler, and F. H. Bach. 1993. Cytokine-inducible expression in endothelial cells of an IκBα-like gene is regulated by NF-κB. EMBO J. 12:2773-2779.
24. Durand, D. B., M. R. Bush, J. G. Morgan, A. Weiss, and G. R. Crabtree. 1987. A 275 basepair fragment at the 5′ end of the interleukin 2 gene enhances expression from a heterologous promoter in response to signals from the T cell antigen receptor. J. Exp. Med. 165:395-407.
25. Frantz, B., E. C. Nordby, G. Bren, N. Steffan, C. V. Paya, R. L. Kincaid. M. J. Tocci, S. J. O'Keefe, and E. A. O'Neill. 1994. Calcineurin acts in synergy with PMA to inactivate IκB/MAD3, an inhibitor of NF-κB. EMBO J. 13:861-870.
26. SRF causes the aberrant induction of cellular immediate early genes through CArG boxes. Genes Dev. 6:2066-2076
27. Ganchi, P., S.-C. Sun, W. C. Greene, and D. W. Ballard. 1992. IκB/MAD-3 masks the nuclear localization signal of NF-κB p65 and requires the transactivation domain to inhibit NF-κB p65 DNA binding. Mol. Biol. Cell 3:1339-1352.
28. Ghosh, S., A. M. Gifford, L. R. Riviere, P. Tempst, G. P. Nolan, and D. Baltimore. 1990. Cloning of the p50 DNA binding subunit of NF-κB: homology to rel and dorsal. Cell 62:1019-1029.
29. Gilman, M. Z., R. N. Wilson, and R. A. Weinberg. 1986. Multiple protein-binding sites in the 5′-flanking region regulate c-fos expression. Mol. Cell. Biol. 6:4305-316.
30. Green, P. L., and I. S. Y. Chen. 1994. Molecular features of the human T-cell leukemia virus, p. 277-311. In J. A. Levy (ed.). The Retroviridae, vol. 3. Plenum Press, New York.
31. Greene, W. C., E. Böhnlein, and D. W. Ballard. 1989. HIV-1, HTLV-1 and normal T-cell growth: transcriptional strategies and surprises. Immunol. Today 10:272-277.
32. Grilli, M., J. Chiu, and M. Lenardo. 1993. NF-κB and Rel: participants in a multiform transcriptional regulatory system. Int. Rev. Cytol. 143:1-62.
33. Haskill, S., A. A. Beg, S. M. Tompkins, J. S. Morris, A. D. Yurochko, A. Sampson-Johannes, K. Mondai, P. Ralph, and A. S. Baldwin, Jr. 1991. Characterization of an immediate-early gene induced in adherent monocytes that encodes IκB-like activity. Cell 65:1281-1289.
34. Hatada, E., M. Naumann, and C. Scheidereit. 1993. Common structural constituents confer IκB activity to NF-IκB p105 and IκB/MAD-3. EMBO J. 12:2781-2788.
35. Henkel, T., T. Machleidt, I. Alkalay, M. Kronke, Y. Ben-Neriah, and P. Baeuerle. 1993. Rapid proteolysis of IκB-α is necessary in the activation of transcription factor NF-IκB. Nature (London) 365:182-185.
36. Hirai, H., J. Fujisawa, T. Suzuki, K. Ueda, M. Muramatsu, A. Tsuboi, N. Arai, and M. Yoshida. 1992. Transcriptional activator Tax of HTLV-I binds to the NF-κB precursor p105. Oncogene 7:1737-1742.
37. Hirai, H., T. Suzuki, J. Fujisawa, J. Inoue, M. Yoshida. 1994. Tax protein of human T-cell leukemia virus type I binds to the ankyrin motifs of inhibitory factor κB and induces nuclear translocation of transcription factor NF-κB proteins for transcriptional activation. Proc. Natl. Acad. Sci. USA 91:3584-3588.
38. Inoue, J.-I., L. D. Kerr, A. Kakizuka, and I. M. Verma. 1992. IκBγ, a 70 kd protein identical to the C-terminal half of p110 NF-κB: a new member of the IκB family. Cell 68:1109-1120.
39. Inoue, J.-I., L. D. Kerr, D. Rashid, N. Bose, Jr., and I. M. Verma. 1992. Direct association of pp40/IκBβ with rel/NF-κB transcription factors: role of ankyrin repeats in the inhibition of DNA binding activity. Proc. Natl. Acad. Sci. USA 89:4333-4337.
40. x encoded by human T-cell leukemia virus type I. EMBO J. 5:2883-2888.
41. + T lymphocytes. Science 256: 1452-1456.
42. Kanno, T., K. Brown, G. Franzoso, and U. Siebenlist. 1994. Kinetic analysis of human T-cell leukemia virus type I Tax-mediated activation of NF-κB. Mol. Cell. Biol. 14:6443-6451.
43. Kieran, M., V. Blank, F. Logeat, J. Vandekerckhove, F. Lottspeich, O. LeBail, M. B. Urban, P. Kourilsky, P. A. Baeuerle, and A. Israël. 1990. The DNA binding subunit of NF-κB is identified to factor KBF1 and homologous to the rel oncogene product. Cell 62:1007-1018.
44. Kimata, J. T., and L. Ratner. 1991. Temporal regulation of viral and cellular gene expression during human T-lymphotropic virus type I-mediated lymphocyte immortalization. J. Virol. 65:3134-3141.
45. Kitajima, I., T. Shinohara, J. Bilakovics, D. A. Brown, X. Xu, and M. Nerenberg. 1992. Ablation of transplanted HTLV-1 Tax-transformed tumors in mice by antisense inhibition of NF-κB. Science 258:1792-1795.
46. Lenardo, M. J., and D. Baltimore. 1989. NF-κB: a pleiotropic mediator of inducible and tissue-specific gene control. Cell 58:227-229.
47. Leung, K., and G. Nabel. 1988. HTLV-1 transactivator induces interleukin-2 receptor expression through an NF-κB-like factor. Nature (London) 333: 776-778.
48. Lowenthal, J., D. W. Ballard, E. Böhnlein, and W. C. Greene. 1989. Tumor necrosis factor alpha induces proteins that bind specifically to κB-like enhancer elements and regulate interleukin 2 receptor alpha-chain gene expression in primary human T lymphocytes. Proc. Natl. Acad. Sci. USA 86:2331-2335.
49. Lowenthal, J. W., E. Böhnlein, D. W. Ballard, and W. C. Greene. 1988. Regulation of interleukin-2 receptor α subunit (Tac or CD25 antigen) gene expression: binding of inducible nuclear proteins to discrete promoter sequences correlates with transcriptional activation. Proc. Natl. Acad. Sci. USA 85:4468-4472.
50. Manger, B., A. Weiss, C. Weyand, J. Goronzy, and J. Stobo. 1985. T cell activation: differences in the signals required for IL-2 production by nonactivated and activated T cells. J. Immunol. 135:3669-3673.
51. x and T3/Ti complex triggering. Cell 48:343-350.
52. Mellits, K. H., R. T. Hay, and S. Goodbourn. 1993. Proteolytic degradation of MAD3 (IκBα) and enhanced processing of the NF-κB precursor p105 are obligatory steps in the activation of NF-κB. Nucleic Acids Res. 21:5059-5066.
53. Mercurio, F., J. A. DiDonato, C. Rosette, and M. Karin. 1993. p105 and p98 precursor proteins play an active role in NF-κB-mediated signal transduction. Genes Dev. 7:705-718.
54. Meyer, R., E. N. Hatada, H.-P. Hohmann, M. Haiker, C. Bartsch, U. Rothlisberger, H.-W. Lahm, E. J. Schlaeger, A. P. G. M. van Loon, and C. Scheidereit. 1991. Cloning of the DNA-binding subunit of human nuclear factor κB: the level of its mRNA is strongly regulated by phorbol ester or tumor necrosis factor a. Proc. Natl. Acad. Sci. USA 88:966-970.
55. Nabel, G., and D. Baltimore. 1987. An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature (London) 326:711-713.
56. Nakamaye, K., and F. Eckstein. 1986. Inhibition of restriction endonuclease Nci I cleavage by phosphothioate groups and its application to oligonucleotide-directed mutagenesis. Nucleic Acids Res. 14:9679-9698.
57. Naumann, M., and C. Scheidereit. 1994. Activation of NF-κB in vivo is regulated by multiple phosphorylations. EMBO J. 13:4597-4607.
58. Naumann, M., F. G. Wulczyn, and C. Sheidereit. 1993. The NF-κB precursor p105 and the proto-oncogene product Bcl-3 are IκB molecules and control nuclear translocation of NF-KB. EMBO J. 12:213-222.
59. Neumann, J., C. Morency, and K. Russian. 1987. A novel rapid assay for chloramphenicol acetyltransferase gene expression. BioTechniques 5:444-447.
60. Nolan, G. P., S. Ghosh, H.-C. Lion, P. Tempst, and D. Baltimore. 1991. DNA binding and IκB inhibition of the cloned p65 subunit of NF-κB, a rel-related polypeptide. Cell 64:961-969.
61. Osborn, L., S. Kunkel, and G. J. Nabel. 1989. Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor-kappa B Proc. Natl. Acad. Sci. USA 86: 2336-2340.
62. Palombella, V. J., O. J. Rando, A. L. Goldberg, and T. Maniatis. 1994. Ubiquitin and the proteasome are required for processing the NF-κB1 precursor and the activation of NF-κB. Cell 78:773-785.
63. Pearson, R. B., and B. E. Kemp. 1991. Protein kinase phosphorylation site sequences and consensus specificity motifs: tabulations. Methods Enzymol. 200:62-81.
64. Prickett, K. S., D. C. Amberg, and T. P. Hopp. 1989. A calcium-dependent antibody for identification and purification of recombinant proteins. Bio-Techniques 7:580-589.
65. Rice, N. R., M. L. MacKichan, and A. Israël. 1992. The precursor of NF-κB p50 has IκB-like functions. Cell 71:243-253.
66. Rogers, S., R. Wells, and M. Rechsteiner. 1986. Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis. Science 234: 364-368.
67. Ruben, S. M., P. J. Dillon, R. Schreck, T. Henkel, C.-H. Chen, M. Maher, P. A. Baeuerle, and C. A. Rosen. 1991. Isolation of a rel-related human cDNA that potentially encodes the p65-kD subunit of NF-κB. Science 251:1490-1493.
68. Ruben, S. M., R. Narayanan, J. Klement, C.-H. Chen, and C. Rosen. 1992. Functional characterization of the NF-κB p65 transcriptional activator and an alternatively sliced derivative. Mol. Cell. Biol. 12:444-454.
69. Ruben, S. M., H. Poteat, T. H. Tan, K. Kawakami, R. Roeder, W. Haseltine, and C. A. Rosen. 1988. Cellular transcription factors and regulation of IL-2 receptor gene expression by HTLV-1 tax gene product. Science 241:89-92.
70. Schmitz, M. L., and P. A. Baeuerle. 1991. The p65 subunit is responsible for the strong transcription activating potential of NF-κB. EMBO J. 10:3805-3817.
71. Schreck, R., R. Grassman, B. Fleckenstein, and P. A. Baeuerle. 1992. Antioxidants selectively suppress activation of NF-κB by human T-cell leukemia virus type I Tax protein. J. Virol. 66:6288-6293.
72. Schreck, R., P. Rieber, and P. A. Baeuerle. 1991. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J. 10:2247-2258.
73. Schreiber, E., P. Matthias, M. Muller, and W. Schaffner. 1989. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res. 17:6419.
74. Schütze, S., K. Potthoff, T. Machleidt, D. Berkovic, K. Wiegmann, and M. Kronke. 1992. TNF activates NF-κB by phosphatidylcholine-specific phospholipase C-induced "acidic" sphingomyelin breakdown. Cell 71:765-776.
75. Sen, R., and D. Baltimore. 1986. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46:705-716.
76. Siekevitz, M., M. B. Feinberg, N. Holbrook, F. Wong-Staal, and W. C. Greene. 1987. Activation of interleukin 2 and interleukin 2 receptor (Tac) promoter expression by the transactivator (tat) gene product of human T-cell leukemia virus type I. Proc. Natl. Acad. Sci. USA 84:5389-5393.
77. Smith, M. R., and W. C. Greene. 1990. Identification of HTLV-1 tax transactivator mutants exhibiting novel transcriptional phenotypes. Genes Dev. 4:1875-1885.
78. Sodroski, J., C. Rosen, W. C. Goh, and W. Haseltine. 1985. A transcriptional activator protein encoded by the x-lor region of human T cell leukemia virus. Science 228:1430-1434.
79. Stein, B., H. Rahmsdorf, A. Steffen, M. Litfin, and P. Herrlich. 1989. UV-induced DNA damage is an intermediate step in UV-indueed expression of human immunodeficiency virus type 1, collagenase. c-Fos, and metallothionein. Mol. Cell. Biol. 9:5169-5181.
80. Sun, S.-C., P. Ganchi, D. W. Ballard, and W. C. Greene. 1993. NF-κB controls expression of inhibitor IκBα: evidence for an inducible autoregulatory pathway. Science 259:1912-1915.
81. Sun, S.-C., P. Ganchi, C. Béraud, D. W. Ballard, and W. C. Greene. 1994. Autoregulation of the NF-κB transactivator RelA (p65) by multiple cytoplasmic inhibitors containing ankyrin motifs. Proc. Natl. Acad. Sci. USA 91:1346-1350.
82. Sun, S.-C., J. Elwood, C. Béraud, and W. C. Greene. 1994. Human T-cell leukemia virus type I tax activation of NF-κB/Rel involves phosphorylation and degradation of IκBα and RelA (p65)-mediated induction of the c-rel gene. Mol. Cell. Biol. 14:7377-7384.
83. Suzuki, T., J. I. Fujisawa, M. Toita, and M. Yoshida. 1993. The transactivator tax of human T-cell leukemia virus type 1 (HTLV-1) interacts with cAMP-responsive element (CRE) binding and CRE modulator proteins that bind to the 21-base-pair enhancer of HTLV-1. Proc. Natl. Acad. Sci. USA 90:610-614.
84. Ten, R. M., C. V. Paya, N. Israel, O. LeBail, M. G. Mattei, J. L. Virelizier, P. Kourilsky, and A. Israël. 1992. The characterization of the promoter of the gene encoding the p50 subunit of NF-κB indicates that it participates in its own regulation. EMBO J. 11:195-203.
85. Tewari, M., P. Dobrzanski, K. L. Mohn, D. E. Cressman, J. C. Hsu, R. Bravo, and R. Taub. 1992. Rapid induction in regenerating liver of RL/IF-1 (an IκB that inhibits NF-κB, RelB-p50, and c-Rel-p50) and PHF, a novel κB site binding complex. Mol. Cell. Biol. 12:2898-2908.
86. Urban, M., and P. Baeuerle. 1990. The 65-kD subunit of NF-κB is a receptor for IκB and a modulator of DNA-binding specificity. Genes Dev. 4:1975-1984.
87. Watanabe, M., M.-A. Muramatsu, H. Hirai, T. Suzuki, J. Fujisawa, M. Yoshida, K.-I. Arai, and N. Arai. 1993. HTLV-I encoded Tax in association with NF-κN precursor p105 enhances nuclear localization of NF-κB p50 and p65 in transfected cells. Oncogene 8:2949-2958.
88. Weiss, A., and D. Littman. 1994. Signal transduction by lymphocyte antigen receptors. Cell 76:263-274.
89. Zhao, L. J., and C. Z. Giam. 1992. Human T-cell lymphotropic virus type I (HTLV-I) transcriptional activator. Tax, enhances CREB binding to HTLV-I 21-base-pair repeats by protein-protein interactions. Proc. Natl Acad. Sci. USA 89:7070-7074.